These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17345122)

  • 21. Peripheral arterial disease: diagnosis and management.
    Arain FA; Cooper LT
    Mayo Clin Proc; 2008 Aug; 83(8):944-49; quiz 949-50. PubMed ID: 18674479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current endovascular treatment of peripheral arterial disease.
    Mardikar HM; Mukherjee D
    Prog Cardiovasc Nurs; 2007; 22(1):31-7. PubMed ID: 17342004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral arterial disease: identification and implications.
    Mohler ER
    Arch Intern Med; 2003 Oct; 163(19):2306-14. PubMed ID: 14581250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical management of peripheral arterial disease: a therapeutic algorithm.
    Lumsden AB; Rice TW
    J Endovasc Ther; 2006 Feb; 13 Suppl 2():II19-29. PubMed ID: 16511954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The burden of peripheral artery disease and the role of antiplatelet therapy.
    Aronow H; Hiatt WR
    Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    Poredos P; Jezovnik MK
    Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral arterial disease: epidemiology and drug therapy.
    McDermott MM
    Am J Geriatr Cardiol; 2002; 11(4):258-66. PubMed ID: 12091774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI of atherosclerosis: diagnosis and monitoring therapy.
    Kramer CM; Anderson JD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):69-80. PubMed ID: 17187458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endovascular treatment of peripheral vascular disease.
    Allaqaband S; Kirvaitis R; Jan F; Bajwa T
    Curr Probl Cardiol; 2009 Sep; 34(9):359-476. PubMed ID: 19664498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of peripheral arterial disease.
    Aronow WS
    Cardiol Rev; 2005; 13(2):61-8. PubMed ID: 15705252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of failure of endovascular therapy for peripheral arterial disease.
    Yacyshyn VJ; Thatipelli MR; Lennon RJ; Bailey KR; Stanson AW; Holmes DR; Gloviczki P
    Angiology; 2006; 57(4):403-17. PubMed ID: 17022375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis.
    Peeters Weem SM; van Haelst ST; den Ruijter HM; Moll FL; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):253-62. PubMed ID: 27241270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options.
    Rockson SG; Cooke JP
    Adv Intern Med; 1998; 43():253-77. PubMed ID: 9506185
    [No Abstract]   [Full Text] [Related]  

  • 35. Office management of peripheral arterial disease.
    Aronow WS
    Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
    Ferreira AC; Macedo FY
    Ann Med; 2010 Mar; 42(2):139-50. PubMed ID: 20156042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
    Hackam DG; Tan MK; Lin PJ; Mehta PG; Jaffer S; Kates M; Oh M; Grima EA; Langer A; Goodman SG; ;
    J Vasc Surg; 2006 Oct; 44(4):776-81. PubMed ID: 16930931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor?
    Al-Omran M; Lindsay TF
    Can J Cardiol; 2005 Feb; 21(2):189-93. PubMed ID: 15729421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions.
    Weiss N; Bergert H
    Vasa; 2009 Nov; 38(4):302-15. PubMed ID: 19998251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of lower extremity peripheral arterial disease.
    Dieter RS; Chu WW; Pacanowski JP; McBride PE; Tanke TE
    Clin Cardiol; 2002 Jan; 25(1):3-10. PubMed ID: 11808837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.